K Number
K251294

Validate with FDA (Live)

Manufacturer
Date Cleared
2025-10-15

(173 days)

Product Code
Regulation Number
872.3630
Panel
Dental
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

Bonafix Implant Abutments are intended for use with dental implants as a support for single-unit or multi-unit prostheses in the maxillary or mandibular arch of a partially or fully edentulous patient.

All digitally designed superstructures, and/or hybrid crowns for use with Titanium Base are to be sent to a Bonafix validated milling center for manufacture.

Device Description

Bonafix Abutment Solutions are a dental implant abutments system that includes three abutment design types (Temporary, Straight Ti-Base and Multi-Unit), that can be used to support single-unit or multi-unit prosthetic restorations. These abutments incorporating interface features compatible with sixteen (16) endosseous dental implant system platforms (Eight (8) designs from five (5) manufactures). The subject device abutments platform diameters range from 3.5mm to 6.3mm, and the corresponding compatible implant body diameters also range from 3.5 mm to 6.3mm. The system also includes corresponding abutment screws.

Temporary Abutments are manufactured from Titanium Grade 5 and consist of a coronal section, a platform and a connection part. The abutments are provided non-sterile with instructions for end user sterilization. The Temporary Abutments are seated in the implant with a prosthetic screw which is also manufactured from Titanium Grade 5. The prosthetic screw is delivered with the abutment. Angular correction of temporary abutments and placement of implant bodies at an angle is not allowed, they must be used parallel to the direction of occlusal loading forces. Temporary Abutments can be used prior to the insertion of the final components to maintain, stabilize and shape the soft tissue during the healing phase; they may not be placed into occlusion. Modifications can be made by the end-user only in the minimum post height. Minimum post height – 4.0 mm. Temporary Abutments have a maximum duration of usage of 180 days.

The Bonafix TiBase abutment is composed of two-piece abutment that is a titanium base at the bottom and a zirconia superstructure (CAD/CAM patient specific superstructure) at the top. The superstructure are fabricated using a CAD/CAM process in Zirconia. The apical end is prefabricated to fit the compatible implant platform, as shown above, and is available with implant connections for crowns (with socket) or bridges (without socket). Angular correction of abutments and placement of implant bodies at an angle is not allowed, they must be used parallel to the direction of occlusal loading forces. Each abutment is provided with a screw designed to fit the compatible implant. The design parameters for the fabrication of the zirconia superstructure, which are already locked in the CAD/CAM software, are as follows: Minimum wall thickness – 0.45 mm, Minimum abutment post height – 4.0 mm, Maximum abutment post height – 6.5mm, Maximum gingival height – 5.0 mm, Minimum gingival height – 0.7 mm, Angulation – 0°. All digitally designed superstructures, and/or hybrid crowns for use with Bonafix TiBase abutments are to be sent to a Zentek validated milling center for manufacture. All superstructures are to be manufactured from zirconia conforming to ISO 13356. The required cement for bonding the zirconia superstructure to the Bonafix TiBase abutments to create the final two-piece abutment is G-CEM LinkAce™ cleared in K120243. Bonafix Ti-Base Abutments are made of titanium alloy (Ti-6Al-4V) conforming to ASTM F136 Standard Specification for Wrought Titanium-6Aluminum-4Vanadium ELI (Extra Low Interstitial) Alloy for Surgical Implant Applications (UNS R56401) with the superstructure made of zirconia conforming to ISO 13356 Implants for surgery – Ceramic materials based on yttria-stabilized tetragonal zirconia (Y-TZP).

The Multi-unit abutments are screw-attached to the implant to restore fully or partially edentulous arches. Their use is not intended for single-unit crowns. They are designed with various gingival heights (1.5, 2.5 and 3.5mm) and can be screwed directly to a compatible implant. They use a titanium Multi-unit sleeve, which is cemented to the prosthesis. Together with a titanium prosthetic screw, the prosthesis is ready to be screwed onto the Multi-unit abutment, which in turn is screwed onto the implant, thus completing the restoration. This multi-unit abutments are not intended to provide angle or divergence correction. For all system, are manufactured from Titanium Grade 5. Multi-unit sleeve can only be modified in the post height and that the minimum post height is 4mm from gingival collar.

The Prosthetic screw is used to seat all abutments for the system, included the temporary abutments and ti-bases, to the dental implant. They are provided along the prosthetic components, but they are also provided as standalone screws. The Abutment screws are manufactured from titanium alloy conforming to ASTM F136.

All system abutments are provided non-sterile with instructions for end user steam sterilization. The subject devices are provided non-sterile and required to be sterilized. All Bonafix TiBase abutments are packaged into PET bag.

AI/ML Overview

N/A

U.S. Food & Drug Administration 510(k) Clearance Letter

Page 1

U.S. Food & Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
www.fda.gov

Doc ID # 04017.08.00

Zentek Medical LLC
℅ Carlos Marín
Consultant
Compliance 4 Devices
118 W Prive Cr.
Delray Beach, Florida 33445

Re: K251294
Trade/Device Name: Bonafix Implant Abutments
Regulation Number: 21 CFR 872.3630
Regulation Name: Endosseous Dental Implant Abutment
Regulatory Class: Class II
Product Code: NHA
Dated: September 11, 2025
Received: September 11, 2025

Dear Carlos Marín:

We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

October 15, 2025

Page 2

Zentek Medical LLC
℅ Carlos Marín
Consultant
Compliance 4 Devices
118 W Prive Cr.
Delray Beach, Florida 33445

October 15, 2025

Re: K251294
Trade/Device Name: Bonafix Implant Abutments
Regulation Number: 21 CFR 872.3630
Regulation Name: Endosseous Dental Implant Abutment
Regulatory Class: Class II
Product Code: NHA
Dated: September 11, 2025
Received: September 11, 2025

Dear Carlos Marín:

We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).

Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.

All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems.

Page 3

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Andrew I. Steen -S

Andrew I. Steen
Assistant Director
DHT1B: Division of Dental and ENT Devices
OHT1: Office of Ophthalmic, Anesthesia,
Respiratory, ENT, and Dental Devices
Office of Product Evaluation and Quality
Center for Devices and Radiological Health

Enclosure

Page 4

FORM FDA 3881 (8/23) Page 1 of 2

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Indications for Use

Form Approved: OMB No. 0910-0120
Expiration Date: 07/31/2026
See PRA Statement below.

510(k) Number (if known): K251294
Device Name: Bonafix Implant Abutments

Indications for Use (Describe)

Bonafix Implant Abutments are intended for use with dental implants as a support for single-unit or multi-unit prostheses in the maxillary or mandibular arch of a partially or fully edentulous patient.

Compatible Implant Systems

Dental implant SystemImplant Body Diameter (mm)Platform Diameter
Neodent GM3.5, 3.75, 4.0, 4.3, 5.0Single Platform
Nobel Replace3.5NP
4.3RP
5.0WP
Biomed 3I Certain3.43.4
4.14.1
5.05.0
Straumann Tissue Level4.1, 4.8RN
4.8WN
Astratech3.5, 4.0Small
4.5, 5.0Large
Straumann BLX3.5, 3.75, 4.0, 4.5RB
Megagen AnyRidge4.0, 4.4Regular
4.9, 5.4, 5.9Wide
Megagen AnyOne3.93.5
4.3, 4.8, 5.3, 6.33.9

All digitally designed superstructures, and/or hybrid crowns for use with Titanium Base are to be sent to a Bonafix validated milling center for manufacture.

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

Page 5

FORM FDA 3881 (8/23) Page 2 of 2

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services
Food and Drug Administration
Office of Chief Information Officer
Paperwork Reduction Act (PRA) Staff
PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

Page 6

Page 1 of 15

Zentek Medical LLC 510(k) Summary K251294

Prepared October 15, 2025

I) Applicant

Submitter: ZENTEK MEDICAL LLC
Address: 200 Craig Rd Ste 107, Manalapan, NJ 077268735
Contact: Michael Vinnik, Owner
Telephone: +1 732-2840545
E-mail: mvinnik2@gmail.com

II) Consultant

Company: COMPLIANCE 4 DEVICES
Address: 118 W Prive Cr., Delray Beach FL, 33445
Contact: Carlos Marín, Juan Tezak
Telephone: +1 561-7892411
E-mail: compliance4devices@gmail.com

III) Device

Trade Name: Bonafix Implant Abutments
Common Name: Dental Implant Abutment
Classification Name: Endosseous dental implant abutment
Regulation Number: 872.3630
Product Code: NHA

IV) Predicate Device

510(k) Number: K221673
Applicant: ZENTEK MEDICAL LLC
Trade Name: Bonafix TiBase
Classification Name: Endosseous dental implant abutment
Regulation Number: 872.3630
Product Code: NHA

V) Reference Device

510(k) Number: K240570
Applicant: IMPLANT PROTESIS DENTAL 2004, S.L
Trade Name: IPD DENTAL IMPLANT ABUTMENTS
Classification Name: Endosseous dental implant abutment
Regulation Number: 872.3630
Product Code: NHA

Page 7

VI) Reference Device

510(k) Number: K242819
Applicant: IMPLANT PROTESIS DENTAL 2004, S.L
Trade Name: IPD DENTAL IMPLANT ABUTMENTS
Classification Name: Endosseous dental implant abutment
Regulation Number: 872.3630
Product Code: NHA

Additional Reference Devices for Compatible Implants:

Compatible Implant SystemImplant Body Diameter (mm)Implant Platform Diameter (mm)K Number
Neodent GM3.5, 3.75, 4.0, 4.3, 5.0Single PlatformK163194
Nobel Replace3.5NPK073142
4.3RP
5.0WPK073142
Biomed 3I Certain3.43.4
4.14.1
5.05.0K130222
Straumann Tissue Level4.1, 4.8RNK101732 and K120414
4.8WN
Astratech3.5, 4.0SmallK191256
4.5, 5.0LargeK181703
Straumann BLX3.5, 3.75, 4.0, 4.5RBK173961
Megagen Anyridge4.0, 4.4RegularK140091
4.9, 5.4, 5.9Wide
Megagen Anyone3.93.5K123988
4.3, 4.8, 5.3, 6.33.9

VII) Indication For Use

Bonafix Implant Abutments are intended for use with dental implants as a support for single-unit or multi-unit prostheses in the maxillary or mandibular arch of a partially or fully edentulous patient.

Compatible Implant SystemImplant Body Diameter (mm)Implant Platform Diameter (mm)
Neodent GM3.5, 3.75, 4.0, 4.3, 5.0Single Platform
Nobel Replace3.5NP
4.3RP
5.0WP
Biomed 3I Certain3.43.4
4.14.1
5.05.0
Straumann Tissue Level4.1, 4.8RN

Page 8

Compatible Implant SystemImplant Body Diameter (mm)Implant Platform Diameter (mm)
4.8WN
Astratech3.5, 4.0Small
4.5, 5.0Large
Straumann BLX3.5, 3.75, 4.0, 4.5RB
Megagen Anyridge4.0, 4.4Regular
4.9, 5.4, 5.9Wide
Megagen Anyone3.93.5
4.3, 4.8, 5.3, 6.33.9

All digitally designed superstructures, and/or hybrid crowns for use with Titanium Base are to be sent to a Bonafix validated milling center for manufacture.

VIII) Device Description

Bonafix Abutment Solutions are a dental implant abutments system that includes three abutment design types (Temporary, Straight Ti-Base and Multi-Unit), that can be used to support single-unit or multi-unit prosthetic restorations. These abutments incorporating interface features compatible with sixteen (16) endosseous dental implant system platforms (Eight (8) designs from five (5) manufactures). The subject device abutments platform diameters range from 3.5mm to 6.3mm, and the corresponding compatible implant body diameters also range from 3.5 mm to 6.3mm. The system also includes corresponding abutment screws.

Temporary Abutments

Are manufactured from Titanium Grade 5 and consist of a coronal section, a platform and a connection part. The abutments are provided non-sterile with instructions for end user sterilization. The Temporary Abutments are seated in the implant with a prosthetic screw which is also manufactured from Titanium Grade 5. The prosthetic screw is delivered with the abutment. Angular correction of temporary abutments and placement of implant bodies at an angle is not allowed, they must be used parallel to the direction of occlusal loading forces.

Temporary Abutments can be used prior to the insertion of the final components to maintain, stabilize and shape the soft tissue during the healing phase; they may not be placed into occlusion. Modifications can be made by the end-user only in the minimum post height.

  • Minimum post height – 4.0 mm

Temporary Abutments have a maximum duration of usage of 180 days.

They are available in the following sizes:

Page 9

SystemsPlatformCharacteristic
NEODENT GMSingle platformEngaging, Non-Engaging
NOBEL REPLACENPEngaging, Non-Engaging
RPEngaging, Non-Engaging
WPEngaging, Non-Engaging
Biomed 3I Certain3.4Engaging, Non-Engaging
4.1Engaging, Non-Engaging
5.0Engaging
Straumann Tissue LevelRNEngaging, Non-Engaging
WNEngaging, Non-Engaging
Straumann BLXRBEngaging, Non-Engaging
Megagen Anyone3.9Engaging, Non-Engaging
4.3, 4.8, 5.3, 6.3Engaging, Non-Engaging

Ti-base Abutments

The Bonafix TiBase abutment is composed of two-piece abutment that is a titanium base at the bottom and a zirconia superstructure (CAD/CAM patient specific superstructure) at the top. The superstructure are fabricated using a CAD/CAM process in Zirconia. The apical end is prefabricated to fit the compatible implant platform, as shown above, and is available with implant connections for crowns (with socket) or bridges (without socket).

Angular correction of abutments and placement of implant bodies at an angle is not allowed, they must be used parallel to the direction of occlusal loading forces.

Each abutment is provided with a screw designed to fit the compatible implant.

The design parameters for the fabrication of the zirconia superstructure, which are already locked in the CAD/CAM software, are as follows:

  • Minimum wall thickness – 0.45 mm
  • Minimum abutment post height – 4.0 mm
  • Maximum abutment post height – 6.5mm
  • Maximum gingival height – 5.0 mm
  • Minimum gingival height – 0.7 mm
  • Angulation – 0°

Page 10

Ti-base Abutments

The Bonafix TiBase abutment is composed of two-piece abutment that is a titanium base at the bottom and a zirconia superstructure (CAD/CAM patient specific superstructure) at the top. The superstructure are fabricated using a CAD/CAM process in Zirconia. The apical end is prefabricated to fit the compatible implant platform, as shown above, and is available with implant connections for crowns (with socket) or bridges (without socket).

Angular correction of abutments and placement of implant bodies at an angle is not allowed, they must be used parallel to the direction of occlusal loading forces.

Each abutment is provided with a screw designed to fit the compatible implant.

The design parameters for the fabrication of the zirconia superstructure, which are already locked in the CAD/CAM software, are as follows:

  • Minimum wall thickness – 0.45 mm
  • Minimum abutment post height – 4.0 mm
  • Maximum abutment post height – 6.5mm
  • Maximum gingival height – 5.0 mm
  • Minimum gingival height – 0.7 mm
  • Angulation – 0°

Note: The abutment post height is defined as the portion of the abutment above the gingival height.

All digitally designed superstructures, and/or hybrid crowns for use with Bonafix TiBase abutments are to be sent to a Zentek validated milling center for manufacture. All superstructures are to be manufactured from zirconia conforming to ISO 13356.

All potential foreign machining center candidates must comply with a quality selection process in which they must meet the following characteristics:

  • Must be registered with the FDA as a medical device manufacturer.
  • Must have a quality system in place under CFR 820.
  • Pass the manufacturing validation tests, which guarantee that the designs elaborated in the program (EXOCAD) are replicated correctly and accurately by the machines used by the supplier.

After passing the validation tests, the manufacturer may be registered within the ZENTEK quality system as a validated supplier for the fabrication of superstructures for ZENTEK Ti-base abutments.

The required cement for bonding the zirconia superstructure to the Bonafix TiBase abutments to create the final two-piece abutment is G-CEM LinkAce™ cleared in K120243

Bonafix Ti-Base Abutments are made of titanium alloy (Ti-6Al-4V) conforming to ASTM F136 Standard Specification for Wrought Titanium-6Aluminum-4Vanadium ELI (Extra Low Interstitial) Alloy for Surgical Implant Applications (UNS R56401) with the superstructure made of zirconia conforming to ISO 13356 Implants for surgery – Ceramic materials based on yttria-stabilized tetragonal zirconia (Y-TZP).

They are available in the following sizes:

SystemsPlatformCharacteristic
NEODENT GMSingle platformEngaging, Non-Engaging
NOBEL REPLACENPEngaging, Non-Engaging
RPEngaging, Non-Engaging
Biomed 3I Certain3.4Engaging, Non-Engaging
4.1Engaging, Non-Engaging
5.0Engaging, Non-Engaging
Straumann Tissue LevelRNEngaging, Non-Engaging
AstratechSmallEngaging, Non-Engaging
LargeEngaging, Non-Engaging

Page 11

SystemsPlatformCharacteristic
Straumann BLXRBEngaging, Non-Engaging
Megagen Anyridge4.0, 4.4Engaging, Non-Engaging
4.9, 5.4, 5.9Engaging, Non-Engaging
Megagen Anyone3.9Engaging, Non-Engaging
4.3, 4.8, 5.3, 6.3Engaging, Non-Engaging

Multi-Unit Straight Abutments

The Multi-unit abutments are screw-attached to the implant to restore fully or partially edentulous arches. Their use is not intended for single-unit crowns. They are designed with various gingival heights (1.5, 2.5 and 3.5mm) and can be screwed directly to a compatible implant. They use a titanium Multi-unit sleeve, which is cemented to the prosthesis. Together with a titanium prosthetic screw, the prosthesis is ready to be screwed onto the Multi-unit abutment, which in turn is screwed onto the implant, thus completing the restoration.

This multi-unit abutments are not intended to provide angle or divergence correction.

For all system, are manufactured from Titanium Grade 5.

Multi-unit sleeve can only be modified in the post height and that the minimum post height is 4mm from gingival collar.

They are available in the following sizes:

SystemsPlatform
NEODENT GMSingle platform
NOBEL REPLACENP
RP
WP
Biomed 3I Certain3.4
4.1
5.0
Straumann Tissue LevelRN
WN
AstratechSmall
Large
Straumann BLXRB
Megagen Anyridge4.0, 4.4
4.9, 5.4, 5.9

Page 12

SystemsPlatformCharacteristic
Straumann BLXRBEngaging, Non-Engaging
Megagen Anyridge4.0, 4.4Engaging, Non-Engaging
4.9, 5.4, 5.9Engaging, Non-Engaging
Megagen Anyone3.9Engaging, Non-Engaging
4.3, 4.8, 5.3, 6.3Engaging, Non-Engaging

Multi-Unit Straight Abutments

The Multi-unit abutments are screw-attached to the implant to restore fully or partially edentulous arches. Their use is not intended for single-unit crowns. They are designed with various gingival heights (1.5, 2.5 and 3.5mm) and can be screwed directly to a compatible implant. They use a titanium Multi-unit sleeve, which is cemented to the prosthesis. Together with a titanium prosthetic screw, the prosthesis is ready to be screwed onto the Multi-unit abutment, which in turn is screwed onto the implant, thus completing the restoration.

This multi-unit abutments are not intended to provide angle or divergence correction.

For all system, are manufactured from Titanium Grade 5.

Multi-unit sleeve can only be modified in the post height and that the minimum post height is 4mm from gingival collar.

They are available in the following sizes:

SystemsPlatform
NEODENT GMSingle platform
NOBEL REPLACENP
RP
WP
Biomed 3I Certain3.4
4.1
5.0
Straumann Tissue LevelRN
WN
AstratechSmall
Large
Straumann BLXRB
Megagen Anyridge4.0, 4.4
4.9, 5.4, 5.9

Other Multi-unit prosthetic device

DevicePlatform
Titanium Sleeve for Multi-unitSingle platform
Screw for multi-unitSingle platform

Prosthetic screw

It is used to seat all abutments for the system, included the temporary abutments and ti-bases, to the dental implant. They are provided along the prosthetic components, but they are also provided as standalone screws. The Abutment screws are manufactured from titanium alloy conforming to ASTM F136.

All system abutments are provided non-sterile with instructions for end user steam sterilization.

SystemsPlatform
NEODENT GMSingle platform
NOBEL REPLACENP
RP
WP
Biomed 3I Certain3.4
4.1
5.0
Straumann Tissue LevelRN
WN
AstratechSmall
Large
Straumann BLXRB
Megagen Anyridge4.0, 4.4
4.9, 5.4, 5.9
Megagen Anyone3.9
4.3, 4.8, 5.3, 6.3

The subject devices are provided non-sterile and required to be sterilized.

All Bonafix TiBase abutments are packaged into PET bag.

IX) Comparison of Technological Characteristics

Zentek Medical LLC, submits the following information in this Premarket Notification (510k) to demonstrate that, for the purpose of FDA´s regulation of medical devices, Bonafix Implant Abutments are substantially equivalent in indications and design principles to the legally marketed predicate device and reference devices shown below.

Page 13

Comparative tables of indications for use and relevant technological characteristics have been provided as follows.

Table 1. Subject and Predicate devices indications for use comparison

Indications for Use Statements

Subject Device - Bonafix Implant abutment
Zentek Medical LLC

Bonafix Implant Abutments are intended for use with dental implants as a support for single-unit or multi-unit prostheses in the maxillary or mandibular arch of a partially or fully edentulous patient.

All digitally designed superstructures, and/or hybrid crowns for use with Titanium Base are to be sent to a Bonafix validated milling center for manufacture.

Predicate Device - Bonafix TiBase abutment (K221673)
Zentek Medical LLC

Bonafix TiBase abutments are intended for use with dental implants as a support for single-unit or multi-unit prostheses in the maxillary or mandibular arch of a partially or fully edentulous patient.

All digitally designed superstructures, and/or hybrid crowns for use with Titanium Base are to be sent to a Bonafix validated milling center for manufacture.

Page 14

Indications for Use Statements

Reference Device - IPD Dental Implant Abutments (K242819)
(Implant Protesis Dental 2004, SL)

IPD Dental Implant Abutments are intended to be used in conjunction with endosseous dental implants in the maxillary or mandibular arch to provide support for single or multiple dental prosthetic restorations.

The zirconia superstructures for use with the Ti Base (Interface) are only intended to be designed and manufactured according to digital dentistry workflow. The workflow system integrates multiple components of the digital dentistry workflow: scan files from intra-oral scanners, CAD software, CAM software, ceramic material, milling machine and associated tooling and accessories.

Page 15

Indications for Use Statements

Reference Device - IPD Dental Implant Abutments (K240570)
(Implant Protesis Dental 2004, SL)

IPD Dental Implant Abutments are intended to be used in conjunction with endosseous dental implants in the maxillary or mandibular arch to provide support for single or multiple dental prosthetic restorations.

The zirconia superstructures for use with the Ti Base (Interface) are only intended to be designed and manufactured according to digital dentistry workflow. The workflow system integrates multiple components of the digital dentistry workflow: scan files from intra-oral scanners, CAD software, CAM software, ceramic material, milling machine and associated tooling and accessories.

The indications for use of subject device in comparison with primary predicate device are verbatim, with the exception of the new implant systems which Bonafix Implant abutments is claiming compatibility for this submission. Further than this, no change in the intended use or indications for use of the Bonafix Implant Abutments has been carried out. The devices are specifically indicated for patients undergoing oral implant surgery to provide support for dental prosthetic restorations.

Page 16

Similarly, for the subject device and primary predicate device, all digitally designed superstructures, and/or hybrid crowns for use with Titanium Base are to be sent to a Bonafix validated milling center for manufacture.

As previously referred, differences may be found in the list of compatible implant systems for subject and predicate devices. Compatibility of the subject abutments with the specific OEM implants is based on engineering and dimensional analysis.

Similarly, the whole set of compatible dental implant systems and their respective 510(k) have been also included in this submission as reference devices.

Despite this, no further differences are found in the device categories included for subject and predicate devices, and same approach is followed for finalizing the zirconia superstructures.

It is Zentek opinion that these differences do not affect the intended use of the subject device, and/or do not raise differences in terms of safety or efficacy.

Table 2. Subject and Predicate devices technological characteristic comparison

ComparisonSubject DevicePredicate DeviceComparison
General Design Features
DeviceBonafix Implant Abutment Zentek Medical LLCBonafix TiBase abutment Zentek Medical LLC (K221673)
Abutment DesignsTemporary Multi-Unit Straight Titanium BaseTitanium BaseSimilar
Prosthesis AttachmentCement-retained Screw-retainedCement-retained Screw-retainedSame
Restoration TypeSingle-unit (Crowns) Multiple-unit (bridges)Single-unit (Crowns) Multiple-unit (bridges)Same
Abutment/Implant Platform Diameter (mm)3.5 – 6.33.0 – 5.7Similar
Abutment AngleTemporary (0°) Multi-unit (0°) Titanium Base (0°)Titanium Base (0°)Same
Materials
Abutment Metallic MaterialTi-6Al-4V alloy (ASTM F136)Titanium alloy, ASTM F136Same
ScrewTi-6Al-4V alloy (ASTM F136)Titanium alloy, ASTM F136Same
SuperstructureZirconia (ISO 13356)ZirconiaSame
CAD/CAM Abutment Design Parameters
Minimum abutment post height, mm4.04.0Same

Page 17

ComparisonSubject DevicePredicate DeviceComparison
Maximum abutment post height, mm6.56.5Same
Maximum gingival height, mm5.05.0Same
Minimum gingival height, mm0.70.7Same
Wall Minimum wall thickness0.430.43Same
Maximum abutment angulationSame
Abutment attachment to implantScrewScrewSame
Prosthesis attachment to abutmentCement-retained Screw-retainedCement-retained Screw-retainedSame
RestorationSingle-unit Multi-unitSingle-unit Multi-unitSame
Abutment/Implant InterfaceInternal connectionInternal connectionSame
Sterilization
Sterilization status and typeNon-sterile End user steam sterilizationNon-sterile End user steam sterilizationSame

Table 3. Subject and Reference devices technological characteristic comparison (Multi-unit)

ComparisonSubject DeviceReference DeviceComparison
General Design Features
DeviceBonafix Implant Abutment Zentek Medical LLCIPD Dental Implant Abutments (Implant Protesis Dental 2004, SL) (K242819)
Abutment DesignsTemporary Multi-Unit Straight Titanium BaseTitanium Base Multi-Unit OverdentureSimilar
Prosthesis AttachmentCement-retained Screw-retainedCement-retained Screw-retainedSame
Restoration TypeSingle-unit (Crowns) Multiple-unit (bridges)Single-unit (Crowns) Multiple-unit (bridges)Same
Abutment/Implant Platform Diameter (mm)3.5 – 6.33.0 – 5.7Similar
Materials

Page 18

ComparisonSubject DevicePredicate DeviceComparison
Maximum abutment post height, mm6.56.5Same
Maximum gingival height, mm5.05.0Same
Minimum gingival height, mm0.70.7Same
Wall Minimum wall thickness0.430.43Same
Maximum abutment angulationSame
Abutment attachment to implantScrewScrewSame
Prosthesis attachment to abutmentCement-retained Screw-retainedCement-retained Screw-retainedSame
RestorationSingle-unit Multi-unitSingle-unit Multi-unitSame
Abutment/Implant InterfaceInternal connectionInternal connectionSame
Sterilization
Sterilization status and typeNon-sterile End user steam sterilizationNon-sterile End user steam sterilizationSame

Table 3. Subject and Reference devices technological characteristic comparison (Multi-unit)

ComparisonSubject DeviceReference DeviceComparison
General Design Features
DeviceBonafix Implant Abutment Zentek Medical LLCIPD Dental Implant Abutments (Implant Protesis Dental 2004, SL) (K242819)
Abutment DesignsTemporary Multi-Unit Straight Titanium BaseTitanium Base Multi-Unit OverdentureSimilar
Prosthesis AttachmentCement-retained Screw-retainedCement-retained Screw-retainedSame
Restoration TypeSingle-unit (Crowns) Multiple-unit (bridges)Single-unit (Crowns) Multiple-unit (bridges)Same
Abutment/Implant Platform Diameter (mm)3.5 – 6.33.0 – 5.7Similar
Materials
AbutmentTi-6Al-4V alloy (ASTM F136)Titanium alloy, ASTM F136Same
ScrewTi-6Al-4V alloy (ASTM F136)Titanium alloy, ASTM F136Same
Sterilization
Sterilization status and typeNon-sterile End user steam sterilizationNon-sterile End user steam sterilizationSame
Multi-unit Abutments
Abutment/Implant Platform Diameter (mm)3.5 – 6.33.0 – 7.0Similar
Prosthetic Platform Diameter (mm)4.84.8Same
Abutment AngleStraight (0°)0°, 17°, 30°Similar
Intended Restoration TypeMulti-unitMulti-unitSame
Gingival Height1.4 – 4.150.9 – 5.0Similar
Surface CoatingUncoatedTiNDifferent

Table 4. Subject and Reference devices technological characteristic comparison (Temporary)

ComparisonSubject DeviceReference DeviceComparison
General Design Features
DeviceBonafix Implant Abutment Zentek Medical LLCIPD Dental Implant Abutments (Implant Protesis Dental 2004, SL) (K240570)
Abutment DesignsTemporary Multi-Unit Straight Titanium BaseHealing Temporary Cementing Ti-BaseSimilar
Prosthesis AttachmentCement-retained Screw-retainedCement-retained Screw-retainedSame
Restoration TypeSingle-unit (Crowns) Multiple-unit (bridges)Single-unit (Crowns) Multiple-unit (bridges)Same
Abutment/Implant Platform Diameter (mm)3.5 – 6.33.0 – 5.7Similar
Materials
AbutmentTi-6Al-4V alloy (ASTM F136)Titanium alloy, ASTM F136Same
ScrewTi-6Al-4V alloy (ASTM F136)Titanium alloy, ASTM F136Same
Sterilization

Page 19

ComparisonSubject DeviceReference DeviceComparison
AbutmentTi-6Al-4V alloy (ASTM F136)Titanium alloy, ASTM F136Same
ScrewTi-6Al-4V alloy (ASTM F136)Titanium alloy, ASTM F136Same
Sterilization
Sterilization status and typeNon-sterile End user steam sterilizationNon-sterile End user steam sterilizationSame
Multi-unit Abutments
Abutment/Implant Platform Diameter (mm)3.5 – 6.33.0 – 7.0Similar
Prosthetic Platform Diameter (mm)4.84.8Same
Abutment AngleStraight (0°)0°, 17°, 30°Similar
Intended Restoration TypeMulti-unitMulti-unitSame
Gingival Height1.4 – 4.150.9 – 5.0Similar
Surface CoatingUncoatedTiNDifferent

Table 4. Subject and Reference devices technological characteristic comparison (Temporary)

ComparisonSubject DeviceReference DeviceComparison
General Design Features
DeviceBonafix Implant Abutment Zentek Medical LLCIPD Dental Implant Abutments (Implant Protesis Dental 2004, SL) (K240570)
Abutment DesignsTemporary Multi-Unit Straight Titanium BaseHealing Temporary Cementing Ti-BaseSimilar
Prosthesis AttachmentCement-retained Screw-retainedCement-retained Screw-retainedSame
Restoration TypeSingle-unit (Crowns) Multiple-unit (bridges)Single-unit (Crowns) Multiple-unit (bridges)Same
Abutment/Implant Platform Diameter (mm)3.5 – 6.33.0 – 5.7Similar
Materials
AbutmentTi-6Al-4V alloy (ASTM F136)Titanium alloy, ASTM F136Same
ScrewTi-6Al-4V alloy (ASTM F136)Titanium alloy, ASTM F136Same
Sterilization
Sterilization status and typeNon-sterile End user steam sterilizationNon-sterile End user steam sterilizationSame
Temporary Abutments
Abutment/Implant Platform Diameter (mm)3.5 – 6.33.0 – 5.7Similar
Abutment AngleStraight (0°)Straight (0°)Similar
Intended Restoration TypeSingle-unit / Multi-unitSingle-unit / Multi-unitSame
Surface CoatingUncoatedAnodizedDifferent

Page 20

The data included in this submission demonstrate substantial equivalence to the predicate and references devices. It is considered that the subject device is substantially equivalent based on the following aspects:

  • Has the same intended use;
  • Uses the same operating principle;
  • Incorporates similar design and same device categories;
  • Incorporates the same materials;
  • It is sterilized using the same processes.

Materials and technological characteristics of the subject device are identical to previously cleared Bonafix Implant Abutments (primary predicate device). Subject device categories are very similar in design, with differences on the proposed compatibilized OEM dental implant systems.

The other reference devices K120243 and K193352 serve as references for the cement and software used in the design of the Bonafix TiBase abutment restoration.

X) Summary of Non-Clinical Testing

The proposed devices have been subject to bench testing to determine fulfilment of design and performance requirements. Bench testing followed the recommendations provided in FDA Guidance Document – Class II Special Controls Guidance Document: Root-form Endosseous Dental Implants and Endosseous Dental Implant Abutments.

Specifically, non-clinical performance testing on the Bonafix Implant Abutments include:

  • Sterilization validation to achieve a SAL of 1 x 10-6 according to ISO 17665-1 to ensure sterilization of the final finished device.
  • Cytotoxicity testing according to ISO 10993-5 to demonstrate that all patient-contacting surfaces are non-cytotoxic.
  • Reverse engineering and dimensional analysis of original manufacturer's components (implants, abutments and screws) to confirm compatibility.
  • Non-clinical worst-case MRI review was performed to evaluate Bonafix Implant Abutments in the MRI environment using scientific rationale and published literature (i.e., Woods, Terry O., Jana G. Delfino, and Sunder Rajan. "Assessment of Magnetically Induced Displacement Force and Torque on Metal Alloys Used in Medical Devices." Journal of Testing and Evaluation 49.2 (2019): 783-795), for the entire system (including all variations of compatible implant bodies, dental abutments, and fixation screws) and material composition. The rationale addressed parameters per the FDA Guidance "Testing and Labeling Medical Devices for Safety in the Magnetic Resonance (MR) Environment", including magnetically induced displacement force and torque.

Non-clinical performance testing leveraged from K221673, previously cleared, showed that Bonafix Implant Abutments met the applicable specifications and requirements.

No clinical testing was performed, the determination of substantial equivalence is supported by nonclinical testing.

XI) Summary of Clinical Testing

No clinical testing was performed in support of this submission.

XII) Conclusion

The conclusions drawn from the non-clinical testing demonstrate that the subject device is as safe, as effective, and performs as well as the legally marketed predicate device K221673 and Reference Devices K242819 and K240570.

§ 872.3630 Endosseous dental implant abutment.

(a)
Identification. An endosseous dental implant abutment is a premanufactured prosthetic component directly connected to the endosseous dental implant and is intended for use as an aid in prosthetic rehabilitation.(b)
Classification. Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)